Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines

The coronavirus diseases 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have threatened the world for more than 2 years. Multiple vaccine candidates have been developed and approved for emergency use by specific markets, but multiple doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Johnny Chun-Chau, Lai, Nelson Cheuk-Yin, Wu, Kam-Chau, Choi, Man-Chung, Ma, Chloe Ho-Yi, Lin, Jayman, Kuok, Cheong-Nang, Leong, Wai-Leng, Lam, Weng-Kei, Hamied, Yusuf Khwaja, Lam, Dominic Man-Kit, Sze, Eric Tung-Po, Kwong, Keith Wai-Yeung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322707/
https://www.ncbi.nlm.nih.gov/pubmed/35891178
http://dx.doi.org/10.3390/vaccines10071014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322707/
https://www.ncbi.nlm.nih.gov/pubmed/35891178
http://dx.doi.org/10.3390/vaccines10071014

Ejemplares similares